Back to search

Article

The Safety and Efficacy of Ramosetron versus Psyllium for the Treatment of Fecal Incontinence (SERAFI) : Study protocol for a randomized trial

2025-05-15

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Fecal incontinence (FI) is a prevalent condition affecting 2% to 21% of the general population, with higher rates in older adults and specific settings such as nursing homes and hospitals. Current treatments include supportive care, biofeedback, anal injections, and sacral nerve stimulation, though these can be invasive or costly. Pharmacological therapies,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e50e20bf-7bfc-5df0-aba3-0e9a1b807925
DOI
10.21203/rs.3.rs-5153650/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Safety and Efficacy of Ramosetron versus Psyllium for the Treatment of Fecal Incontinence (SERAFI) : Study protocol for a randomized trialDOI 10.21203/rs.3.rs-5153650/v1
Select a neighboring publication to make it the new centre.